摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(4R,5R)-5-[3,5-bis(phenylmethoxy)phenyl]-2,2-dimethyl-1,3-dioxolan-4-yl]methanol | 184914-51-0

中文名称
——
中文别名
——
英文名称
[(4R,5R)-5-[3,5-bis(phenylmethoxy)phenyl]-2,2-dimethyl-1,3-dioxolan-4-yl]methanol
英文别名
——
[(4R,5R)-5-[3,5-bis(phenylmethoxy)phenyl]-2,2-dimethyl-1,3-dioxolan-4-yl]methanol化学式
CAS
184914-51-0
化学式
C26H28O5
mdl
——
分子量
420.505
InChiKey
HETPPEQKYRJKAF-JWQCQUIFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    31
  • 可旋转键数:
    8
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    57.2
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Constitution, Configuration, and the Optical Activity of Chiral Dendrimers
    摘要:
    Three series of zeroth to second generation chiral dendrimers, 7-9, 10-12, and 13-15, were prepared by convergent methods using chiral, nonracemic AB(2) monomers 1, 2, and 3, respectively. Chiroptical data revealed a significant change in molar rotation per subunit ([Phi](D)/n) as dendrimer generation increased for dendrimers 7-9 and 10-12, but not for dendrimers 13-15, a possible indication of chiral conformational order in the former two series of dendrimers, but not in the last. However, the optical activities ([Phi](D)) of low-molecular-weight model compounds 16 (+262) and 17 (+122), prepared to simulate different regions of the dendrimer structure, suggest that as generation size increases slight constitutional changes have a strong effect on the chiroptical properties of the dendrimer subunits. Using the [Phi](D) values of these and other (18-23) low-molecular-weight model compounds, we calculated [Phi](D) values for dendrimers 7-15 that agree within 14% of the observed values. Agreement between the optical activity of the model compounds and the dendrimers leads to the conclusion that the conformational equilibria of the dendrimer subunits are not perturbed relative to those of the model compounds. Therefore, we interpreted the change in [Phi](D)/n as dendrimer generation increased for dendrimers 7-12 to be based solely on constitutional changes in the dendritic structure and not chiral conformational order.
    DOI:
    10.1021/ja970150i
  • 作为产物:
    描述:
    3,5-二苄氧基苯甲醇 在 lithium aluminium tetrahydride 、 甲基磺酰胺 、 K2 、 Celite 、 sodiumpotassium carbonate对甲苯磺酸氢化奎尼定 1,4-(2,3-二氮杂萘)二醚pyridinium chlorochromate 、 potassium hexacyanoferrate(III) 作用下, 以 乙醚乙醇二氯甲烷N,N-二甲基甲酰胺甲苯叔丁醇 为溶剂, 反应 74.75h, 生成 [(4R,5R)-5-[3,5-bis(phenylmethoxy)phenyl]-2,2-dimethyl-1,3-dioxolan-4-yl]methanol
    参考文献:
    名称:
    Asymmetric Synthesis of a Series of Chiral AB2 Monomers for Dendrimer Construction
    摘要:
    Efficient preparation of a series of four chiral, nonracemic AB(2) monomers suitable for the construction of dendrimers is presented. Monomers 1-4 possess the common structural features of a diphenolic moiety and a benzylic or aliphatic hydroxyl which render these molecules suitable for convergent dendrimer synthesis. The same basic, high-yielding, five-step sequence is employed for 1-4. Stilbene derivatives 13 and 14 are prepared by a Horner-Wadsworth-Emmons modified Wittig reaction between 3,5- or 3,4-bis(benzyloxy)benzaldehyde (8 and 10) and an ester-substituted benzylphosphonate (11 or 12). Cinnamate derivatives 21 and 22 are prepared similarly from 8 and 10 and triethyl phosphonoacetate. Chirality is introduced in the form of a 1,2-diol unit by Sharpless asymmetric dihydroxylation (AD) (>97% ee in all cases), Protection of the 1,2-diols as their acetonide derivatives provides dioxolane intermediates 17, 18, 25, and 26. Reduction of the ester groups followed by hydrogenolysis of the benzyl ethers yields AB(2) monomers 1-4 in 57-67% overall yield from 8 and 10.
    DOI:
    10.1021/jo961587w
点击查看最新优质反应信息

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯